The Valley Desk

NCT04633239 · Interventional trial

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Overall registry status Recruiting

Phase 1

Conditions Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov